Evaluation of chikusetsusaponin IVa isolated from Alternanthera philoxeroides for its potency against viral replication

Planta Medica

Volumn 75, Issue 8, 2009, Pages 829-835

  Rattanathongkom, Ariya ^a   Lee, Jung Bum ^b   Hayashi, Kyoko ^b   Sripanidkulchai, Bung Orn ^a   Kanchanapoom, Tripetch ^a   Hayashi, Toshimitsu ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Alternanthera philoxeroides (Amarantheaceae); Antiviral activity; Chikusetsusaponin IV a; Genital herpes; Herpes simplex virus type 2

Indexed keywords

ANTIVIRUS AGENT; CALENDULOSIDE E; CHIKUSETSU SAPONIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALTERNANTHERA PHILOXEROIDES; AMARANTHACEAE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; GENITAL HERPES; GROWTH INHIBITION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IC 50; MEASLES VIRUS; MOUSE; MUMPS VIRUS; NONHUMAN; PROTEIN SYNTHESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INACTIVATION; VIRUS PARTICLE; VIRUS REPLICATION;

AMARANTHACEAE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; OLEANOLIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; SAPONINS; VIRUS DISEASES; VIRUS REPLICATION;

ALTERNANTHERA PHILOXEROIDES; AMARANTHACEAE; HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 5; IVA; MEASLES VIRUS; MUMPS VIRUS;

EID: 69049083430     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185436     Document Type: Article

References (29)

1. Bean B. Antiviral therapy: current concepts and practices. Clin Microbiol Rev 1992; 5: 146-182
2. Snoeck R. Antiviral therapy of herpes simplex. Int J Antimicrob Agents 2000; 16: 157-159
3. Fang JB, Duan HQ, Zhang YW, Yoshihisa T. Chemical constituents from herb of Alternanthera philoxeroides. Zhongguo Zhong Yao Za Zhi 2006; 31: 1072-1075
4. Zhang SM, He YS, Tabba HD, Smith KM. Inhibitor against the human immunodeficiency virus in aqueous extracts of Alternanthera philoxeroides. Chin Med J 1988; 101: 861-866 (Pubitemid 19104893)
5. Jiang WL, Luo XL, Kuang SJ. Effect of Alternanthera philoxeroides Griseb against dengue virus in vitro. Di Yi Junyi Daxuw Xuebao 2005; 25: 454-456
6. Gohar AA, Maatooq GT, Niwa M, Yoshiaki T. A new treterpene saponin from Chenopodium ficifolium. Z Naturforsch C 2002; 57: 597-602 (Pubitemid 35008516)
7. Chiu LC, Zhu W, Ooi VE. A polysaccharide fraction from medicinal herb Prunella vulgaris downregulates the expression of herpes simplex virus antigen in Vero cells. J Ethnopharmacol 2004; 93: 63-68 (Pubitemid 38739271)
8. Hayashi K, Hayashi T, Ujita K, Takaishi Y. Characterization of antiviral activity of a sesquiterpene, triptofordin C-2. J Antimicrob Chemother 1996; 37: 759-768 (Pubitemid 26135347)
9. Hoshino T, Hayashi T, Hayashi K, Hamada J, Lee JB, Sankawa U. An antivirally active sulfated polysaccharide from Sargassum horneri (TURNER) C. AGARDH. Biol Pharm Bull 1998; 21: 730-734
10. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938; 27: 493-497
11. Sakamoto T, Ushijima H, Okitsu S, Suzuki E, Sakai K, Morikawa S, Müller WEG. Establishment of an HIVcell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene. J VirolMethods 2003; 114: 159-166 (Pubitemid 37415126)
12. Kanekiyo K, Hayashi K, Takenaka H, Lee JB, Hayashi T. Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga Nostoc flagelliforme. Biol Pharm Bull 2007; 30: 1573-1575 (Pubitemid 47282209)
13. Huang AS, Wagner RR. Penetration of herpes simplex virus into human epidermoid cells. Proc Soc Exp Biol Med 1964; 116: 863-869
14. Roner MR, Sprayberry J, Spinks M, Dhanji S. Antiviral activity obtained from aqueous extract of the Chilean soapbark tree (Quillaja saponaria Malina). J Gen Virol 2007; 88: 275-285 (Pubitemid 46085139)
15. Sindambiwe JB, Calomme M, Geerts S, Pieters L, Vlietinck AJ, Vanden Berghe DA. Evaluation of biological activities of triterpenoid saponins from Maesa lancealata. J Nat Prod 1998; 61: 585-590 (Pubitemid 28262022)
16. Amoros M, Fauconnier B, Girre RL. In vitro antiviral activity of a saponin from Anagallis arvnsis, Primulaceae, against herpes simplex virus and poliovirus. Antiviral Res 1987; 8: 13-25
17. Apers S, Baronikava S, Sindambiwe JB, Witvrouw M, De Clercq E, Vanden Berghe D, Van Marck E, Vietinck A, Pieters L. Antiviral, haemolytic and molluscicidal activities of triterpenoid saponins from Maesa lanceolata: establishment of structure-activity relationships. Planta Med 2001; 67: 528-532 (Pubitemid 32800418)
18. Hayashi K, Hayashi H, Hiraoka N, Ikeshiro Y. Inhibitory activity of soyasaponin II on virus replication in vitro. Planta Med 1997; 63: 102-105 (Pubitemid 27196073)
19. Chiang LC, Ng LT, Liu LT, Shieh DE, Lin CC. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med 2003; 69: 705-709
20. Cheng PW, Ng LT, Chiang LC, Lin CC. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol 2006; 33: 612-616
21. Yoo HH, Kwon SW, Park JH. The cytotoxic saponin from heat-processed Achyranthes fauriei roots. Biol Pharm Bull 2006; 26: 1053-1055
22. Hosono-Nishiyama K, Matsumoto T, Kiyohara H, Nishizawa A, Atsumi T, Yamada H. Suppression of Fas-mediated apoptosis of keratinocyte cells by chikusetsusaponins isolated from the roots of Panax japonicus. Planta Med 2006; 72: 93-98
23. Yoshikawa M, Murakami T, Komatsu H, Matsuda H. Medical foodstuffs. XII. Saponin constituents with adjuvant activity from hyacinth bean, the seeds of Dolichos lablab L. (1): structures of lablabosides A, B, and C. Chem Pharm Bull 1998; 46: 812-816
24. Kinjo J, Okawa M, Udayama M, Sohno Y, Hirakawa T, Shii Y, Nohara T. Hepatopreventive and hepatotoxic actions of oleanolic acid-type cultures. Chem Pharm Bull 1999; 47: 290-292
25. Arvin AM, Prober CG. Herpes simplex virus type 2 - a persistent problem. N Engl J Med 1997; 337: 1158-1159 (Pubitemid 27444108)
26. CohenMS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998; 351: 5-7 (Pubitemid 128643728)
27. Corey L, Handfield HH. Genital herpes and public health: addressing a global problem. JAMA 2000; 283: 791-794 (Pubitemid 30084620)
28. Spieler Trager R. Raising new barriers against HIV infection. Science 2003; 299: 39
29. Keller MJ, Klotman ME, Herold BC. Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus. Am J Reprod Immunol 2003; 49: 279-284 (Pubitemid 36581966)